North America Drug Discovery Markets, 2020-2021 & 2030 by Drug Type, Service, Process, Technology, Therapeutic Area, End User – ResearchAndMarkets.com

North America Drug Discovery Markets, 2020-2021 & 2030 by Drug Type, Service, Process, Technology, Therapeutic Area, End User – ResearchAndMarkets.com




North America Drug Discovery Markets, 2020-2021 & 2030 by Drug Type, Service, Process, Technology, Therapeutic Area, End User – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “North America Drug Discovery Market 2020-2030 by Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

North America drug discovery market is expected to grow by 7.9% annually in the forecast period and reach $41.44 billion by 2030.

The market is driven by the rising demand for specialty medicines, the surge in lifestyle-oriented diseases and the advancements in technology, the growing elderly population and the rising healthcare expenses, rising expenditure on R&D, and expiration of patents.

The report is based on studies on 2017-2019 and provides estimate for 2020 and forecast from 2021 till 2030 with 2019 as the base year (Year 2020 is not appropriate for research base due to the outbreak of COVID-19).

The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify North America drug discovery market in every aspect of the classification from perspectives of Drug Type, Service, Process, Technology, Therapeutic Area, End User, and Country.

Key Players

  • Abbott Laboratories Inc.
  • Agilent Technologies Inc.
  • Astrazeneca plc
  • Bayer AG
  • Charles River Laboratories International Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd
  • GlaxoSmithKline PLC
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Shimadzu Corp
  • Thermo Fisher Scientific Inc.

Key Topics Covered:

1 Introduction

1.1 Industry Definition and Research Scope

1.2 Research Methodology

1.3 Executive Summary

2 Market Overview and Dynamics

2.1 Market Size and Forecast

2.1.1 Impact of COVID-19 on World Economy

2.1.2 Impact of COVID-19 on the Market

2.2 Major Growth Drivers

2.3 Market Restraints and Challenges

2.4 Emerging Opportunities and Market Trends

2.5 Porter’s Five Forces Analysis

3 Segmentation of North America Market by Drug Type

3.1 Market Overview by Drug Type

3.2 Small Molecule Drugs

3.3 Biologic Drugs

4 Segmentation of North America Market by Service

4.1 Market Overview by Service

4.2 Medicinal Chemical Services

4.3 Biological Services

4.4 Drug Metabolism and Pharmacokinetics (DMPK) Services

4.5 Other Pharmaceutical Services

5 Segmentation of North America Market by Process

5.1 Market Overview by Process

5.2 Target Selection

5.3 Target Validation

5.4 Hit-To-Lead Identification

5.5 Lead Optimization

5.6 Candidate Validation

6 Segmentation of North America Market by Technology

6.1 Market Overview by Technology

6.2 High Throughput Screening

6.3 Combinatorial Chemistry

6.4 Pharmacogenomics and Pharmacogenetics

6.5 Nanotechnology

6.6 Bioanalytical Instruments

6.7 Biochips

6.8 Bioinformatics

6.9 Other Technologies

7 Segmentation of North America Market by Therapeutic Area

7.1 Market Overview by Therapeutic Area

7.2 Oncology

7.3 Neurology

7.4 Infectious and Immune System Diseases

7.5 Digestive System Diseases

7.6 Cardiovascular Diseases

7.7 Diabetes

7.8 Respiratory Disease

7.9 Other Therapeutic Areas

8 Segmentation of North America Market by End User

8.1 Market Overview by End User

8.2 Pharmaceutical Companies

8.3 Contract Research Organizations (CROs)

8.4 Research Institutes

8.5 Other End Users

9 North America Market 2019-2030 by Country

9.1 Overview of North America Market

9.2 U.S.

9.3 Canada

9.4 Mexico

10 Competitive Landscape

10.1 Overview of Key Vendors

10.2 New Product Launch, Partnership, Investment, and M&A

10.3 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/r/jqst4a

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900